Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

N-glycan based biomarker distinguishing non-alcoholic steatohepatitis from steatosis independently of fibrosis.

Blomme B, Francque S, Trépo E, Libbrecht L, Vanderschaeghe D, Verrijken A, Pattyn P, Nieuwenhove YV, Putte DV, Geerts A, Colle I, Delanghe J, Moreno C, Gaal LV, Callewaert N, Vlierberghe HV.

Dig Liver Dis. 2012 Apr;44(4):315-22. doi: 10.1016/j.dld.2011.10.015. Epub 2011 Nov 25.

PMID:
22119618
2.

Serum protein N-glycosylation in paediatric non-alcoholic fatty liver disease.

Blomme B, Fitzpatrick E, Quaglia A, De Bruyne R, Dhawan A, Van Vlierberghe H.

Pediatr Obes. 2012 Apr;7(2):165-73. doi: 10.1111/j.2047-6310.2011.00024.x. Epub 2012 Feb 10.

PMID:
22434757
3.

Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.

Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.

Obes Surg. 2006 Dec;16(12):1584-93.

PMID:
17217634
4.

Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis.

Chen C, Schmilovitz-Weiss H, Liu XE, Pappo O, Halpern M, Sulkes J, Braun M, Cohen M, Barak N, Tur-Kaspa R, Vanhooren V, Van Vlierberghe H, Libert C, Contreras R, Ben-Ari Z.

J Proteome Res. 2009 Feb;8(2):463-70. doi: 10.1021/pr800656e.

PMID:
19140676
5.

Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery.

Trak-Smayra V, Dargere D, Noun R, Albuquerque M, Yaghi C, Gannagé-Yared MH, Bedossa P, Paradis V.

Gut. 2009 Jun;58(6):825-32. doi: 10.1136/gut.2007.140087. Epub 2008 Apr 10.

PMID:
18403495
6.

Non-alcoholic steatohepatitis in children.

Nanda K.

Pediatr Transplant. 2004 Dec;8(6):613-8. Review.

PMID:
15598336
7.

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.

Wong VW, Wong GL, Choi PC, Chan AW, Li MK, Chan HY, Chim AM, Yu J, Sung JJ, Chan HL.

Gut. 2010 Jul;59(7):969-74. doi: 10.1136/gut.2009.205088.

PMID:
20581244
8.

Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis.

Kayadibi H, Gültepe M, Yasar B, Ince AT, Ozcan O, Ipcioglu OM, Kurdas OO, Bolat B, Benek YZ, Guveli H, Atalay S, Ozkara S, Keskin O.

Dig Dis Sci. 2009 Aug;54(8):1764-71. doi: 10.1007/s10620-008-0535-0. Epub 2008 Nov 7.

PMID:
18989777
9.

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients.

Singh DK, Rastogi A, Sakhuja P, Gondal R, Sarin SK.

Indian J Pathol Microbiol. 2010 Jul-Sep;53(3):408-13. doi: 10.4103/0377-4929.68246.

10.

Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful?

Kazemi-Shirazi L, Veloso MP, Frommlet F, Steindl-Munda P, Wrba F, Zehetmayer S, Marsik C, Ferenci P.

Wien Klin Wochenschr. 2008;120(1-2):25-30. doi: 10.1007/s00508-007-0921-1.

PMID:
18239988
11.

Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.

Ito S, Yukawa T, Uetake S, Yamauchi M.

Alcohol Clin Exp Res. 2007 Jan;31(1 Suppl):S83-7.

PMID:
17331172
12.

[Clinical and histological features of non-alcoholic fatty liver disease].

Shi JP, Xun YH, Hu CB, Zhang L, Liu H, Lou GQ, Fan JG.

Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):812-6. Chinese.

PMID:
19958638
13.

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, Rafiq N, Goodman Z, Chandhoke V, Baranova A.

Obes Surg. 2008 Nov;18(11):1430-7. doi: 10.1007/s11695-008-9506-y. Epub 2008 May 24.

PMID:
18500507
14.

Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.

Liew PL, Lee WJ, Wang W, Lee YC, Chen WY, Fang CL, Huang MT.

Obes Surg. 2008 Jul;18(7):847-53. doi: 10.1007/s11695-007-9355-0. Epub 2008 May 6.

PMID:
18459024
15.

Use of non-invasive serum glycan markers to distinguish non-alcoholic steatohepatitis from simple steatosis.

Yamasaki Y, Nouso K, Miyahara K, Wada N, Dohi C, Morimoto Y, Kinugasa H, Takeuchi Y, Yasunaka T, Kuwaki K, Onishi H, Ikeda F, Miyake Y, Nakamura S, Shiraha H, Takaki A, Iwasaki Y, Amano M, Nishimura S, Yamamoto K.

J Gastroenterol Hepatol. 2015 Mar;30(3):528-34. doi: 10.1111/jgh.12726.

PMID:
25168691
16.

Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery.

Barker KB, Palekar NA, Bowers SP, Goldberg JE, Pulcini JP, Harrison SA.

Am J Gastroenterol. 2006 Feb;101(2):368-73.

PMID:
16454845
17.

Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.

Coulon S, Francque S, Colle I, Verrijken A, Blomme B, Heindryckx F, De Munter S, Prawitt J, Caron S, Staels B, Van Vlierberghe H, Van Gaal L, Geerts A.

Cytokine. 2012 Aug;59(2):442-9. doi: 10.1016/j.cyto.2012.05.001. Epub 2012 May 31.

PMID:
22658783
18.

Obesity and non-alcoholic fatty liver disease in chronic hepatitis C.

Younossi ZM, McCullough AJ, Ong JP, Barnes DS, Post A, Tavill A, Bringman D, Martin LM, Assmann J, Gramlich T, Mullen KD, O'Shea R, Carey WD, Ferguson R.

J Clin Gastroenterol. 2004 Sep;38(8):705-9.

PMID:
15319656
19.

Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.

Weiner RA.

Dig Dis. 2010;28(1):274-9. doi: 10.1159/000282102. Epub 2010 May 7.

PMID:
20460923
20.

IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients.

García-Galiano D, Sánchez-Garrido MA, Espejo I, Montero JL, Costán G, Marchal T, Membrives A, Gallardo-Valverde JM, Muñoz-Castañeda JR, Arévalo E, De la Mata M, Muntané J.

Obes Surg. 2007 Apr;17(4):493-503.

PMID:
17608262

Supplemental Content

Support Center